Brain/Neural Hand Exoskeleton Control for Restoration of Bimanual Tasks
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04440709 |
Recruitment Status : Unknown
Verified June 2020 by University Hospital Tuebingen.
Recruitment status was: Recruiting
First Posted : June 22, 2020
Last Update Posted : June 22, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Spinal Cord Injury Stroke | Device: Brain/neural hand exoskeleton (B/NHE) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 10 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Restoration of Bimanual Activities of Daily Living Using a Brain/Neural Hand Exoskeleton (B/NHE) in Hand Paralysis |
Estimated Study Start Date : | June 2020 |
Estimated Primary Completion Date : | July 2020 |
Estimated Study Completion Date : | October 2020 |

Arm | Intervention/treatment |
---|---|
Experimental: Brain/neural hand exoskeleton (B/NHE) |
Device: Brain/neural hand exoskeleton (B/NHE)
The brain/neural hand exoskeleton restores hand motor function by translating user's intention into grasping motions |
- Change in Berlin Bimanual Task Assessment (BEBITA) score [ Time Frame: Hand function will be assessed twice on the same day. Once before the hand exoskeleton is applied (absence of the assistive device) and once after the brain-controlled hand exoskeleton was attached to the patients' hand and arm. ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 68 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria (Stroke):
- single ischemic or hemorrhagic insult with subcortical lesion (medullary canal, internal capsula, pedunculi cerebri)
- interval since stroke at least 6 months
- substantial motor deficit with:
- Medical Research Council (MRC) -score of less than 2 out of 6 possible points (0=no activity; 1=visible contraction without motor effect; 2=movements with elimination of gravity; 3=movements against gravity; 4=movements against weak resistance; 5=normal force)
- Fugl-Meyer Test (upper extremity) of less than 31 points, "no to little mobility"
Inclusion Criteria (Spinal Cord Injury):
- cervical spinal cord injury, height C5-C6
- interval after spinal cord injury at least 6 months
- substantial motor deficit with American Spinal Cord Association (ASIA) -Classification B or C (A=no muscle function/sensitivity below the spinal cord injury; B=no muscle function, limited sensitivity present; C=low non-relevant muscle function, sensitivity present; D=functionally relevant muscle functions present; E=fully preserved or restored functions)
Exclusion Criteria (Stroke and Spinal Cord Injury):
- Alcohol or drug problem (regular consumption of more than 2 alcoholic beverages per day, or taking illegal drugs)
- currently undergoing neurological or psychiatric treatment based on a secondary diagnosis
- Severe and uncontrollable medical problems:
- Non-adjusted malignant high blood pressure, World Health Organization (WHO) Hypertension Grade II
- non-adjustable diabetes mellitus, HbA1c > 58 mmol/mol
- renal failure, from KDIGO glomerular filtration rate (GFR) category G3b (moderate to severe impairment)
- Liver failure, Child-Pugh stages B and C
- Heart failure New York Heart Association (NYHA) grade III-IV
- malignant tumor disease
- severe arrhythmia in need of treatment
- severe oedemas
- severe arthritis
- serious cognitive impairment (minimum status below 23 points)
- Severe spasticity (Ashworth grade ≥ 4)
- Pregnancy
- Bilateral motor deficit (in stroke patients)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04440709
Contact: Surjo R. Soekadar, MD | +49-163-1644889 | surjo.soekadar@uni-tuebingen.de |
Germany | |
University Hospital Tuebingen | Recruiting |
Tuebingen, BW, Germany, 72076 | |
Contact: Surjo R. Soekadar, MD +49-163-1644889 surjo.soekadar@uni-tuebingen.de | |
Charité - University Medicine Berlin | Recruiting |
Berlin, Germany, 10117 | |
Contact: Surjo R Soekadar, MD +49 30 450 528 153 surjo.soekadar@charite.de |
Responsible Party: | University Hospital Tuebingen |
ClinicalTrials.gov Identifier: | NCT04440709 |
Other Study ID Numbers: |
NEU007/1 |
First Posted: | June 22, 2020 Key Record Dates |
Last Update Posted: | June 22, 2020 |
Last Verified: | June 2020 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Spinal Cord Injuries Spinal Cord Diseases Central Nervous System Diseases |
Nervous System Diseases Trauma, Nervous System Wounds and Injuries |